If you’ve been diagnosed with fibromyalgia, relief may seem a lifetime away. From all-over aches, pains and fatigue to memory, mood, and sleep issues, fibromyalgia takes its toll every day. And with no known cause or cure, your suffering can seem never-ending.
The good news is that you don’t have to live this way. The Helen Foundation’s Microdose Therapy™ is a proven, and simple treatment for inflammation and chronic pain that’s used to treat a wide range of conditions, including fibromyalgia.
Microdose Therapy™ gives you control of your pain management, and delivers real relief within as little as three weeks!
In this blog, we’ll explore what that relief actually feels like, from reduction of tenderness in many parts of the body to a full night’s sleep thanks to pain relief with Microdose Therapy™, a revolutionary treatment for anyone who’s suffering from fibromyalgia.
Breakthrough Fibromyalgia Pain Relief Management
Inflammation is one of fibromyalgia’s biggest symptoms, but inflammation itself is not necessarily a bad thing. The body reacts to trauma with inflammation, and releases cortisol to help bring the body back to where it was before.
Under normal circumstances, the body produces a large amount of cortisol to reduce swelling, redness, heat, and pain after a traumatic event. Once the trauma is under control, the body gradually reverts back to the amount of cortisol it produces on a daily basis (less than 25mg/daily).
With inflammatory diseases and disorders, the body’s ability to treat swelling, redness, heat, and pain is compromised, making it difficult to heal itself as usual.
Microdose Therapy™ involves the use of cortisol—something the body naturally produces—and has been extensively studied and peer reviewed. One such study was a 2019 clinical study published in the Journal of Inflammation Research, where cortisol was conclusively proven to provide 77% symptom relief for patients with fibromyalgia.1
The use of Microdose Therapy™ for fibromyalgia pain relief treatment was as much as three times higher than the medications commonly prescribed:
- Duloxetine: Provided between 17-30% symptom relief
- Pregabalin: Provided between 26-31% symptom relief
- Milnacipran: Provided between 35-42% symptom relief
- Microdose Therapy™: Provided 77% symptom relief
The study proved just how effective Microdose Therapy™ is for fibromyalgia and other inflammatory diseases, controlling multiple symptoms with one simple approach.
What Real Relief Looks Like
Microdose Therapy™ doesn’t just provide relief—it leaves traditional therapies in the dust, with triple the relief of medications like Duloxetine and Pregabalin.
Within just three weeks, Microdose Therapy™ delivers a dramatic relief in pain and fatigue, and reduces tenderness across the body. And that means better sleep, and a better overall quality of life.
Without the burden of inflammation and chronic pain, Microdose Therapy™ gives patients their lives back, beginning with pain management. Guided support and daily pain diaries help patients customize their medication needs to keep their symptoms under control.
But don’t just take our word for it… see what some of our patients had to say!
“When I started Microdose Therapy™, I could hardly even walk, but now I can do almost everything…I’ve even planted a tiny garden!”
84 year old patient diagnoses with osteoarthritis and fibrositis
Achieved a 96% reduction in symptoms
“I started Microdose Therapy™ with a pain score that was over 70. Now, I feel human again with an average score of 8 and my life is back to normal.”
Mid-50s patient diagnosed with fibrositis
Achieved an 85% reduction in symptoms
Life Without Fibromyalgia Pain
With Microdose Therapy™, you don’t have to suffer through painful symptoms of fibromyalgia. And you don’t have to sacrifice your quality of life relying on costly treatments that just don’t work.
It may surprise you, but Microdose Therapy™ is not a new fibromyalgia treatment. This same therapeutic concept dates back well over a century—pioneering research into the use of cortisone to treat rheumatoid arthritis, another inflammatory disease even received a Nobel prize in the late 1940s!
Discover a better life beyond the pain, whether you’re a patient or a provider. Take the next step today and call The Helen Foundation for more information at 812-864-3536.
Resource:
- Irwin JB, Baldwin AL, Stenberg VI. General theory of inflammation: patient self-administration of hydrocortisone safely achieves superior control of hydrocortisone-responding disorders by matching dosage with symptom intensity. J Inflamm Res. 2019;12:161-166 https://doi.org/10.2147/JIR.S195165